The Oxford-AstraZeneca coronary vaccine has been approved by the Drug Enforcement Administration of India. A Reuters report quoted an unnamed source as saying. That being said, the country could be vaccinated from next Wednesday.
Corona vaccine ‘Covishield’ is being prepared at the Serum Institute of India (SII) in India in a joint venture between Oxford University and pharmaceutical company AstraZeneca. The United Kingdom has previously approved the vaccine on an emergency basis. An expert committee formed by the Indian Ministry of Health also met on Wednesday to discuss emergency implementation. In all, there have been two meetings in the last three days. At Friday’s meeting, experts made the necessary recommendations for the urgent application of the Oxford University’s Covishield vaccine. According to the Times of India, the expert committee in India has analyzed the details of the various stages of vaccine testing to see if it is safe and effective.
This time, the recommendation or clearance will be sent to the Drug Controller General of India (DCGI) for consideration, Indian media NDTV reported. No drugs or vaccines may be used or administered in India without the final approval of the DCGI.
According to a Reuters report, the DCGI has decided to approve Kovishield. However, no official concerned has commented publicly on the matter.
At Friday’s meeting, Seram Institute and Bharat Biotech presented detailed information about their vaccine. These two organizations applied for permission to use the ticker urgently. The two vaccines were considered at Friday’s meeting. Pfizer-Bioentech was also on the same list. However, Pfizer asked for more time to present detailed data.
India has already started mass vaccination exercises. It is scheduled to start in the state from tomorrow Saturday. The country’s Union Health Minister Harsh Vardhan said preparations have been made for the national elections. The main goal is to avoid errors when the true vaccine is given.